Survival analysis underscored a significant association between high FCN1 expression and prolonged OS in PD1-treated ccRCC and CTLA4-treated melanoma cohorts (Figures 5E, F). This evidence concerns the gene CTLA4 and nonpapillary renal cell carcinoma.